BSE Code: | NSE Code: | ISIN: | Sector:
Research Report Detail
|Report Date||Call||Price@Call||Target Price
|Current Status||Time Horizon|
|Target Hit|| Long (1Y)
Macquarie maintains outperform on Dr Reddy's
US business is under appreciated by the Street. Niche approvals over last year are positive for the stock. Recommend adding aggressively at current levels. Target Rs 3325.